login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
AVIDITY BIOSCIENCES INC (RNA) Stock News
USA
- NASDAQ:RNA -
US05370A1088
-
Common Stock
70
USD
+20.85 (+42.42%)
Last: 10/27/2025, 8:00:02 PM
69.9
USD
-0.1 (-0.14%)
After Hours:
10/27/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
RNA Latest News, Press Relases and Analysis
All
Press Releases
6 hours ago - By: Chartmill
- Mentions:
IRBT
PRE
DYN
SOHO
...
Which stocks are moving on Monday?
8 hours ago - By: Chartmill
- Mentions:
IRBT
GGAL
BMA
DYN
...
Keep an eye on the top gainers and losers in Monday's session.
2 hours ago - By: Kahn Swick & Foti, LLC
Avidity Biosciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avidity Biosciences, Inc. - RNA
5 hours ago - By: The Motley Fool
- Mentions:
NVS
Why Avidity Biosciences Stock Blasted 42% Higher Today
6 hours ago - By: Brodsky & Smith LLC
- Mentions:
WTRG
CADE
PLYM
AWK
...
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Essential Utilities, Inc. (NYSE – WTRG), Cadence Bank (NYSE – CADE), Avidity Biosciences, Inc. (Nasdaq – RNA), Plymouth Industrial REIT, Inc. (NYSE – PLYM)
7 hours ago - By: Benzinga
- Mentions:
NVS
Avidity Biosciences Soars After $72 Per Share Novartis Takeover
7 hours ago - By: Stocktwits
- Mentions:
SPY
QCOM
TSLA
NTLA
...
Qualcomm, Tesla, Intellia Therapeutics, Avidity Biosciences, Dyne Therapeutics: Stocks Making The Biggest Moves Today
10 hours ago - By: Stocktwits
- Mentions:
DYN
NVS
Dyne Therapeutics Stock Soars After Rival Avidity Biosciences Gets Acquired By Novartis
10 hours ago - By: Chartmill
- Mentions:
IRBT
GGAL
BMA
UAMY
...
Which stocks are gapping on Monday?
12 hours ago - By: Chartmill
- Mentions:
GGAL
BMA
PRE
SOHO
...
These stocks are moving in today's pre-market session
15 hours ago - By: Stocktwits
- Mentions:
SPY
DIA
NVDA
AMD
Dow Futures Rise As China Trade Tensions Ease: NVDA, MP, BA, RNA Among Stocks To Watch
16 hours ago - By: Stocktwits
- Mentions:
IWC
NVS
XBI
Why Avidity Biosciences Stock Is Jumping Over 43% In Premarket Today
a day ago - By: Halper Sadeh LLC
RNA STOCK ALERT: HALPER SADEH LLC IS INVESTIGATING WHETHER THE SALE OF AVIDITY BIOSCIENCES, INC. IS FAIR TO SHAREHOLDERS
a day ago - By: Yahoo Finance
- Mentions:
NVS
NOVN
Novartis to acquire Avidity Biosciences for about $12 billion
a day ago - By: Bloomberg
- Mentions:
NVS
Novartis Agrees to Buy Avidity Biosciences for $72 Per Share
a day ago - By: Avidity Biosciences, Inc.
Avidity Biosciences Enters into Agreement to be Acquired by Novartis AG
a day ago - By: Bloomberg
- Mentions:
NVS
Novartis Said to Near $70-Per-Share-Plus Deal for Avidity
5 days ago - By: Benzinga
Is Avidity Biosciences Inc Gaining or Losing Market Support?
12 days ago - By: Avidity Biosciences, Inc.
Avidity Biosciences to Participate in Upcoming Investor Conference
15 days ago - By: Avidity Biosciences, Inc.
Avidity Biosciences Announces Positive Pre-BLA Meeting with U.S. FDA for del-zota in DMD44 with a Submission Planned for Q1 2026
22 days ago - By: Avidity Biosciences, Inc.
Avidity Biosciences to Present Data from EXPLORE44® Clinical Development Program of Del-Zota in DMD44 at 30th Annual Congress of the World Muscle Society
a month ago - By: Avidity Biosciences, Inc.
Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
2 months ago - By: Avidity Biosciences, Inc.
Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock
Please enable JavaScript to continue using this application.